The AVITHRAPID consortium "Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases" is part of the Horizon Europe Framework Programme and consists of 18 participants and partners from 8 countries.
Project
Description
Outcome &
Deliverables
Research
Repositories
Latest News & Events from AVITHRAPID
Workshop ” Biology and Applications of Extracellular Vesicles”
On Wednesday 12 February 2025, a workshop entitled “Biology and Applications of Extracellular Vesicles” was held in the Aula Magna “Carlo Perone Pacifico”, of the Department of Agricultural and Forestry Sciences, University of Tuscia, partner of Avithrapid consortium. It was organized by
AVITHRAPID Joins Bluesky: A New Space to Connect with the Scientific Community
AVITHRAPID is a project designed to tackle global challenges in antiviral research through an innovative and multidisciplinary approach. Our vision extends beyond laboratory work and scientific publications—we believe in fostering connections, engaging with the scientific community, and sharing our work with a
Breaking News: AVITHRAPID Publishes Key Data to Accelerate Drug Development for Dengue
Breaking News: AVITHRAPID Publishes Key Data to Accelerate Drug Development for Dengue AVITHRAPID has announced a breakthrough in the fight against dengue fever by publishing critical protein models for all four dengue virus (DENV) serotypes. These open-access data represent a transformative step